Emma is a Consultant Pharmacist at the Royal Marsden Hospital in London. She has an MSc in Clinical Oncology and is an Independent Prescriber. Emma is currently Chair of The British Oncology Pharmacy Association (BOPA) as well as Chair of the ISOPP Biosimilars Taskforce and a reviewer for the Journal of Oncology Pharmacy Practice, UK.
She was awarded the BOPA/PRUK research award in 2018 for a study investigating drug interactions between enzalutamide and DOACs. Emma is a visiting lecturer at the University of Brighton and enjoys hosting the annual BOPA Symposium. Her special interests include renal cancer, drug interactions, non-medical prescribing (and canoeing!).